tiprankstipranks
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
US Market
ORIC
Oric Pharmaceuticals
RESEARCH TOOLSreports

Oric Pharmaceuticals (ORIC) Stock News & Sentiment

Compare
493 Followers
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
Premium
Ratings
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
17d ago
ORIC
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Differentiated PRC2 Inhibitor Rinzimetostat Mitigates Sector Safety Overhang and Supports Buy Rating
18d ago
ORIC
Oric Pharmaceuticals Launches New 2026 ATM Share Program
Premium
Company Announcements
Oric Pharmaceuticals Launches New 2026 ATM Share Program
1M ago
8K
ORIC
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
Premium
Stock Analysis & Ideas
Piper Sandler Puts its Weight Behind 2 ‘Strong Buy’ Cancer Stocks
2M ago
OLMA
ORIC
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
Premium
Ratings
ORIC Pharmaceuticals: Dense Near‑Term Clinical Catalysts and Encouraging Efficacy Data Underpin Reiterated Buy Rating
2M ago
ORIC
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
Premium
Market News
3 Best Biotech Stocks to Buy Today, 1/7/2026, According to Top Analysts
3M ago
OLMA
ORIC
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
Premium
Company Announcements
Oric Pharmaceuticals Highlights Promising Enozertinib Trial Results
4M ago
8K
ORIC
More ORIC News >

ORIC News on the Web

Rinzimetostat Shows Promise Against Prostate Cancer Resistance—ORIC's AACR 2026 Presentations Highlight Key Preclinical Findings
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), MindWalk Holdings (HYFT) and Erasca (ERAS)
TipRanks News
Bullish
Oric selloff brings favorable entry point, says H.C. Wainwright
TipRanks News
Bullish
Oric Pharmaceuticals reports Q4 revenue C$17.39M vs. C$18.04M last year
TipRanks News
Neutral
Constructive Buy Thesis on ORIC Driven by Differentiated PRC2 Biology and Manageable Safety Profile for Rinzimetostat
TipRanks News
Bullish
Oric Pharmaceuticals selloff a buying opportunity, says JPMorgan
TipRanks News
Bullish
Cantor says Oric move down on tazemetostat withdrawal an ‘over-reaction’
TipRanks News
Bullish
Midday Fly By: Hims & Hers reaches Novo deal, Live Nation settles with DOJ
TipRanks News
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORIC’s Media Buzz Sentiment?
Currently, no data Available
What is ORIC’s weekly average amount of articles?
Currently, no data Available
What is ORIC’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
KODKodiak Sciences
GILDGilead Sciences, Inc. Shs Unsponsored Canadian Depository Receipt Hedged Reg S
RZLTRezolute
2359WuXi AppTec Co., Ltd. Class H
CNTXContext Therapeutics
Showing the stocks with the most bullish news sentiment over the past week